Lv11
30 积分 2025-04-17 加入
Neoadjuvant Chemoimmunotherapy in Resectable NSCLC With PD-L1 Expression < 1%: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
1小时前
待确认
Cadonilimab plus chemotherapy as first-line treatment in PD-L1-negative advanced non-small cell lung cancer: a phase II clinical trial
2个月前
已完结
Clinical efficacies of different neoadjuvant therapies for non-small cell lung cancer
9个月前
已完结
皖公网安备34019202002308
